-5%
Anidula is indicated for the treatment of invasive fungal infections, including:
Candidemia and other Candida infections (such as intra-abdominal abscess and peritonitis) in adults and pediatric patients aged 1 month and older
Esophageal candidiasis in adults
Anidulafungin inhibits β-1,3-D-glucan synthase, an enzyme present in fungal cells but absent in mammalian cells. This inhibition prevents the synthesis of 1,3-β-D-glucan, an essential structural component of the fungal cell wall, leading to fungal cell death.